Skip Header

1 - 25 of 53 results for author:"Tate S." in Literature citations

Page of 3 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (38)

Structural implication for the impaired binding of W150A mutant LOX-1 to oxidized low density lipoprotein, OxLDL.

Nakano S., Sugihara M., Yamada R., Katayanagi K., Tate S.

Biochim. Biophys. Acta 1824:739-749(2012) · Mapped (1)

Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor.

Bisson N., James D.A., Ivosev G., Tate S.A., Bonner R., Taylor L., Pawson T.

Nat. Biotechnol. 29:653-658(2011) · Mapped (4)

The NMR structure of FliK, the trigger for the switch of substrate specificity in the flagellar type III secretion apparatus.

Mizuno S., Amida H., Kobayashi N., Aizawa S., Tate S.

J. Mol. Biol. 409:558-573(2011) · Mapped (1)

Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors.

Afify A.M., Tate S., Durbin-Johnson B., Rocke D.M., Konia T.

Int. J. Biol. Markers 26:50-57(2011) · Mapped (6)

Surface plasmon resonance study on functional significance of clustered organization of lectin-like oxidized LDL receptor (LOX-1).

Ohki I., Amida H., Yamada R., Sugihara M., Ishigaki T., Tate S.

Biochim. Biophys. Acta 1814:345-354(2011) · Mapped (3)

Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study.

Kasperaviciute D., Catarino C.B., Heinzen E.L., Depondt C., Cavalleri G.L., Caboclo L.O., Tate S.K., Jamnadas-Khoda J., Chinthapalli K., Clayton L.M. et al.

Brain 133:2136-2147(2010) · Mapped (4)

Cloning and characterization of dihydrofolate reductases from deep-sea bacteria.

Murakami C., Ohmae E., Tate S., Gekko K., Nakasone K., Kato C.

J. Biochem. 147:591-599(2010) · UniProtKB (4)

Proline cis/trans-isomerase Pin1 regulates peroxisome proliferator-activated receptor gamma activity through the direct binding to the activation function-1 domain.

Fujimoto Y., Shiraki T., Horiuchi Y., Waku T., Shigenaga A., Otaka A., Ikura T., Igarashi K., Aimoto S., Tate S. et al.

J. Biol. Chem. 285:3126-3132(2010) · Mapped (13)

Phosphorylated intrinsically disordered region of FACT masks its nucleosomal DNA binding elements.

Tsunaka Y., Toga J., Yamaguchi H., Tate S., Hirose S., Morikawa K.

J. Biol. Chem. 284:24610-24621(2009) · Mapped (3)

No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy.

Lynch J.M., Tate S.K., Kinirons P., Weale M.E., Cavalleri G.L., Depondt C., Murphy K., O'Rourke D., Doherty C.P., Shianna K.V. et al.

Epilepsy Res. 83:44-51(2009) · Mapped (4)

Serum YKL-40 as a marker for cervical adenocarcinoma.

Mitsuhashi A., Matsui H., Usui H., Nagai Y., Tate S., Unno Y., Hirashiki K., Seki K., Shozu M.

Ann. Oncol. 20:71-77(2009) · Mapped (4)

Protein phosphatase 1 regulates the phosphorylation state of the polarity scaffold Par-3.

Traweger A., Wiggin G., Taylor L., Tate S.A., Metalnikov P., Pawson T.

Proc. Natl. Acad. Sci. U.S.A. 105:10402-10407(2008) · Mapped (42)

Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study.

Cavalleri G.L., Weale M.E., Shianna K.V., Singh R., Lynch J.M., Grinton B., Szoeke C., Murphy K., Kinirons P., O'Rourke D. et al.

Lancet Neurol 6:970-980(2007) · Mapped (19)

Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1A.

Heinzen E.L., Yoon W., Tate S.K., Sen A., Wood N.W., Sisodiya S.M., Goldstein D.B.

Am. J. Hum. Genet. 80:876-883(2007) · Mapped (9)

Chimeric structural stabilities in the coiled-coil structure of the NECK domain in human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1).

Ishigaki T., Ohki I., Utsunomiya-Tate N., Tate S.I.

J. Biochem. 141:855-866(2007) · Mapped (3)

Tautomerism of histidine 64 associated with proton transfer in catalysis of carbonic anhydrase.

Shimahara H., Yoshida T., Shibata Y., Shimizu M., Kyogoku Y., Sakiyama F., Nakazawa T., Tate S., Ohki S.Y., Kato T. et al.

J. Biol. Chem. 282:9646-9656(2007) · Mapped (2)

The voltage-gated sodium channel Na(v)1.9 is an effector of peripheral inflammatory pain hypersensitivity.

Amaya F., Wang H., Costigan M., Allchorne A.J., Hatcher J.P., Egerton J., Stean T., Morisset V., Grose D., Gunthorpe M.J. et al.

J. Neurosci. 26:12852-12860(2006) · Mapped (2)

A common polymorphism in the SCN1A gene associates with phenytoin serum levels at maintenance dose.

Tate S.K., Singh R., Hung C.C., Tai J.J., Depondt C., Cavalleri G.L., Sisodiya S.M., Goldstein D.B., Liou H.H.

Pharmacogenet. Genomics 16:721-726(2006) · Mapped (7)

Distinct DNA methylation activity of Dnmt3a and Dnmt3b towards naked and nucleosomal DNA.

Takeshima H., Suetake I., Shimahara H., Ura K., Tate S., Tajima S.

J. Biochem. 139:503-515(2006) · UniProtKB (2)

Purification, crystallization and preliminary X-ray analysis of the ligand-binding domain of human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1).

Ishigaki T., Ohki I., Oyama T., Machida S., Morikawa K., Tate S.

Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 61:524-527(2005) · Mapped (3)

Upregulation of the voltage-gated sodium channel beta2 subunit in neuropathic pain models: characterization of expression in injured and non-injured primary sensory neurons.

Pertin M., Ji R.R., Berta T., Powell A.J., Karchewski L., Tate S.N., Isom L.L., Woolf C.J., Gilliard N., Spahn D.R. et al.

J. Neurosci. 25:10970-10980(2005) · Mapped (2)

Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis.

Noton E.A., Colnaghi R., Tate S., Starck C., Carvalho A., Ko Ferrigno P., Wheatley S.P.

J. Biol. Chem. 281:1286-1295(2006) · UniProtKB (2) · Mapped (8)

Assembly and disassembly of nucleosome core particles containing histone variants by human nucleosome assembly protein I.

Okuwaki M., Kato K., Shimahara H., Tate S., Nagata K.

Mol. Cell. Biol. 25:10639-10651(2005) · UniProtKB (2) · Mapped (7)

Solution structure of the HMG-box domain in the SSRP1 subunit of FACT.

Kasai N., Tsunaka Y., Ohki I., Hirose S., Morikawa K., Tate S.

J. Biomol. NMR 32:83-88(2005) · UniProtKB (1) · Mapped (1)

Resonance assignments for the DNA binding domain of ERCC-1/XPF heterodimer.

Masuyama M., Ishino S., Nishino T., Moriuchi H., Ueno H., Morikawa K., Tate S.

J. Biomol. NMR 32:175-175(2005) · Mapped (8)

to top of page·

Page of 3 | Next »